| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2025-12-03 | Mr. David G. ElsleyPresident, CEO & Director | 350.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 675.00k | 107.69% |
| 2025-12-03 | Mr. Christopher J. WaddickCFO, Corporate Secretary & Director | 250.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 250.00k | - |
| 2025-12-03 | Mr. Colin G. StottIndependent Director | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 60.00k | - |
| 2025-12-03 | Ms. Jennifer M. ChaoIndependent Director | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 60.00k | - |
| 2025-12-03 | Mr. Peter PekosIndependent Director | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 60.00k | - |
| 2025-12-03 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 250.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 250.00k | - |
| 2025-12-03 | Ms. Teri LoxamIndependent Director | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 120.00k | 100.00% |
| 2025-12-03 | Dr. Guillermo Torre-AmioneIndependent Chairman | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 60.00k | - |
| 2025-12-03 | Mr. Bernard LimCOO | 250.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 250.00k | - |
| 2025-12-03 | Dr. Timothy J. GarnettIndependent Director | 60.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 1.00 | 120.00k | 100.00% |
| 2025-10-01 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 133.33k | 0.00 | Derivative Exercise and Retained Stock | - | 669.95k | 24.85% |
| 2025-10-17 | Mr. David G. ElsleyPresident, CEO & Director | 100.00k | 100.00k | 買い | 1.00 | 1.34M | 8.04% |
| 2025-10-17 | Dr. Guillermo Torre-AmioneIndependent Chairman | 50.00k | 50.00k | 買い | 1.00 | 309.31k | 19.28% |
| 2025-09-08 | Ms. Teri LoxamIndependent Director | 13.33k | 0.00 | Derivative Exercise and Retained Stock | - | 133.33k | 11.11% |
| 2025-09-08 | Ms. Jennifer M. ChaoIndependent Director | 13.33k | 0.00 | Derivative Exercise and Retained Stock | - | 133.33k | 11.11% |
| 2025-09-08 | Dr. Andrew Warwick HamerChief Medical Officer and Head of Research & Development | 70.00k | 0.00 | Derivative Exercise and Retained Stock | - | 536.61k | 15.00% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。